Stereotaxis is trading at $1.10, up 5.24%, with no specific catalyst identified for the November 6 rise.

  • No company-specific announcement explaining the move was identified; Stereotaxis’ latest listed release was November 2.
  • Stereotaxis is scheduled to report third-quarter results after market close on November 10.
  • Healthcare was down, while major indexes were mixed-to-higher, so the supplied market context does not clearly explain the gain.